Abstract

Techniques for the detection of disease biomarkers are key components in the protection of human health. While work over the last few decades has redefined the low-level measurement of disease biomarkers, the translation of these capabilities from the formal clinical setting to point-of-need (PON) usage has been much more limited. This paper presents the results of experiments designed to examine the potential utility of a handheld Raman spectrometer as a PON electronic reader for a sandwich immunoassay based on surface-enhanced Raman scattering (SERS). In so doing, the study herein used a recently developed procedure for the SERS detection of phospho-myo-inositol-capped lipoarabinomannan (PILAM) as a means to compare the performance of laboratory-grade and handheld instrumentation and, therefore, gauge the utility of the handheld instrument for PON deployment. Phospho-myo-inositol-capped lipoarabinomannan is a non-pathogenic simulant for mannose-capped lipoarabinomannan (ManLAM), which is an antigenic marker found in serum and other body fluids of individuals infected with tuberculosis (TB). The results of the measurements with the field-portable spectrometer were then compared to those obtained for the same samples when using a much more sensitive benchtop Raman spectrometer. The results, albeit under different operational settings for the two spectrometers (e.g., signal integration time), are promising in that the limit of detection found for PILAM spiked in human serum when using the handheld system (0.18 ng/mL) approached that of the benchtop instrument (0.032 ng/mL). This work also: (1) identified potential adaptations (e.g., optimization of the plasmonically enhanced response for measurement by the handheld unit through a change in the excitation wavelength) to tighten the gap in performance; and (2) briefly examined the next steps and potential processes required to move this immunoassay platform closer to PON utility.

© 2018 The Author(s)

Diagnostic potential of polarized surface enhanced Raman spectroscopy technology for colorectal cancer detection

Duo Lin, Hao Huang, Sufang Qiu, Shangyuan Feng, Guannan Chen, and Rong Chen
Opt. Express 24(3) 2222-2234 (2016)

Optical biosensor based on SERS with signal calibration function for quantitative detection of carcinoembryonic antigen

Tingyin Wang, Youzhi Zhu, Shuyun Weng, Xueliang Lin, Kien Voon Kong, Youliang Weng, Xianggang Jia, Rong Chen, Duo Lin, and Shangyuan Feng
Biomed. Opt. Express 13(11) 5962-5970 (2022)

Trace cancer biomarker quantification using polystyrene-functionalized gold nanorods

Jian Wu, Wei Li, Ghazal Hajisalem, Ariella Lukach, Eugenia Kumacheva, Fraser Hof, and Reuven Gordon
Biomed. Opt. Express 5(12) 4101-4107 (2014)

Simultaneous detection of circulating tumor DNAs using a SERS-based lateral flow assay biosensor for point-of-care diagnostics of head and neck cancer

Guang Li, Shengjie Ge, Ping Niu, Jianyou Zhang, Yu Mao, Youwei Wang, and Aidong Sun
Biomed. Opt. Express 13(8) 4102-4117 (2022)

Noninvasive liver diseases detection based on serum surface enhanced Raman spectroscopy and statistical analysis

Xiaozhou Li, Tianyue Yang, Siqi Li, Lili Jin, Deli Wang, Dagang Guan, and Jianhua Ding
Opt. Express 23(14) 18361-18372 (2015)